NCT05839015

Brief Summary

Since the beginning of Covid-19, there has been an increase in the incidence of mental disorders and psychopathological symptoms, such as depression, anxiety and stress, among university students. Even with the end of social distancing, many students still have losses in emotional well-being, so psychotherapeutic interventions are important for the recovery and promotion of the mental health of this public. Interventions based on self-compassion have been associated with improving the mental health of different audiences, either by reducing psychopathological symptoms (such as anxiety) or improving positive constructs associated with mental health, such as hope and optimism. One way to administer interventions based on self-compassion is through mHealth technologies, which have been consolidating since the pandemic. Some studies sought to assess the benefits of self-compassion-based interventions administered in the mHealth format among university students suggest that they have acceptability and are effective regarding indicators of emotional well-being. However, in Brazil, there is still no digital intervention for the cultivation of self-compassion among university students, which could help to mitigate the deleterious effects of the pandemic on mental health. Considering this gap, an intervention based on self-compassion administered via a smartphone app called "Eu + Compassivo" was developed. The present study seeks to evaluate its efficacy in mental health indicators, both psychopathological symptoms and Positive Psychology constructs.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 14, 2022

Completed
7 months until next milestone

First Posted

Study publicly available on registry

May 3, 2023

Completed
11 months until next milestone

Study Start

First participant enrolled

March 20, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

March 20, 2024

Status Verified

March 1, 2024

Enrollment Period

4 months

First QC Date

October 14, 2022

Last Update Submit

March 18, 2024

Conditions

Outcome Measures

Primary Outcomes (6)

  • Change in Depression

    Depression, Anxiety and Stress Scale (DASS-21) - The measure has 21 items arranged in 3 dimensions (depression, anxiety and stress) through a Likert scale ranging from "did not apply to me at all" (0) to "applied to me very much, or most of the time" (3). The sum of the items provides a score between 0 and 21 regarding depression. The higher the score, the greater the depression.

    T1 (pre) to T2 (6-week)

  • Change in Anxiety

    Depression, Anxiety and Stress Scale (DASS-21) - The measure has 21 items arranged in 3 dimensions (depression, anxiety and stress) through a Likert scale ranging from "did not apply to me at all" (0) to "applied to me very much, or most of the time" (3). The sum of the items provides a score between 0 and 21 regarding anxiety. The higher the score, the greater the anxiety.

    T1 (pre), T2 (6-week)

  • Change in Stress

    Depression, Anxiety and Stress Scale (DASS-21) - The measure has 21 items arranged in 3 dimensions (depression, anxiety and stress) through a Likert scale ranging from "did not apply to me at all" (0) to "applied to me very much, or most of the time" (3). The sum of the items provides a score between 0 and 21 regarding stress. The higher the score, the greater the stress.

    T1 (pre), T2 (6-week)

  • Change in Self-Compassion

    Self-Compassion Scale - The measure has 26 items scored on a Likert scale, ranging from "almost never" (1) to "almost always" (5). The higher the score, the greater the sel-compassion.

    T1 (pre), T2 (6-week)

  • Change in Compassion

    Santa Clara Brief Compassion Scale - The measure has 5 items arranged on a Likert scale, ranging from "not at all true for me" (1) to "very true for me" (7). The higher the score, the greater the compassion.

    T1 (pre), T2 (6-week)

  • Change in Emotional Well-Being

    Well-being Index (WHO-5) - It is a generic measure that assesses emotional well-being. It has 5 items, ranging from "at no time" (0) to "all the time" (5) on a Likert scale, providing a score that varies between 0 and 25. The higher the score, the greater the emotional well-being.

    T1 (pre), T2 (6-week)

Secondary Outcomes (6)

  • Change in Hope

    T1 (pre), T2 (6-week)

  • Change in Emotional Self-Regulation

    T1 (pre), T2 (6-week)

  • Change in Positive Affect

    T1 (pre), T2 (6-week)

  • Change in Negative Affect

    T1 (pre), T2 (6-week)

  • Change in Optimism

    T1 (pre), T2 (6-week)

  • +1 more secondary outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

This is group wil use "Eu + Compassivo" app.

Behavioral: mHealth Intervention Based on Self-Compassion

Control

NO INTERVENTION

This group will be made up of a waiting list.

Interventions

Self-compassion techniques aim at developing compassionate skills for emotion regulation, such as self-kindness, recognition of common humanity, and mindfulness.

Intervention

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Must be enrolled in a course that originally works in the face-to-face format
  • Having basic knowledge of the use of smartphones
  • Owning a smartphone with internet access and the Android or IOS system
  • At least mild depressive, anxiety or stress symptoms

You may not qualify if:

  • Diagnosed with any serious and persistent mental disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Caroline Tozzi Reppold, PhD

    Federal University of Health Sciences of Porto Alegre

    PRINCIPAL INVESTIGATOR
  • Prisla Ücker Calvetti, PhD

    Federal University of Health Sciences of Porto Alegre

    PRINCIPAL INVESTIGATOR
  • Sílvio César Cazella, PhD

    Federal University of Health Sciences of Porto Alegre

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Bruno Luis Schaab, MSc.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 14, 2022

First Posted

May 3, 2023

Study Start

March 20, 2024

Primary Completion

July 30, 2024

Study Completion

December 30, 2024

Last Updated

March 20, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share